Skip to content

Clinical trials

Lung Neoplasms trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Unknown status Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20022
20042
20053
20061
20073
20081
20093
20112
20122
20141
20153
20163
20171
20181
20193
20203
20216
20223
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status67

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital3
AstraZeneca2
Garden State Cancer Center at the Center for Molecular Medicine and Immunology2
Jonsson Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
Raghu Nandan, M.D., Inc2
Tularik2
University of Wisconsin, Madison2
Accuray Incorporated1
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms67
Carcinoma, Non-Small-Cell Lung37
Breast Neoplasms11
Head and Neck Neoplasms7
Pancreatic Neoplasms7
Small Cell Lung Carcinoma7
Colonic Neoplasms6
Neoplasms6
Adenocarcinoma of Lung5
Colorectal Neoplasms5

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.